IN190975B - - Google Patents

Info

Publication number
IN190975B
IN190975B IN86DE1999A IN190975B IN 190975 B IN190975 B IN 190975B IN 86DE1999 A IN86DE1999 A IN 86DE1999A IN 190975 B IN190975 B IN 190975B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Sudershan Kumar Arora
Nawal Kishore
Jang Bahadur Gupta
Vishwas Dattatraya Joshi
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN86DE1999 priority Critical patent/IN190975B/en
Priority to US09/276,368 priority patent/US6590085B1/en
Priority to TR2001/02043T priority patent/TR200102043T2/xx
Priority to AT00900088T priority patent/ATE250074T1/de
Priority to BR0007553-1A priority patent/BR0007553A/pt
Priority to JP2000593621A priority patent/JP2002534530A/ja
Priority to DK00900088T priority patent/DK1147119T3/da
Priority to CZ20012540A priority patent/CZ20012540A3/cs
Priority to IL14427300A priority patent/IL144273A0/xx
Priority to PCT/IB2000/000022 priority patent/WO2000042054A1/en
Priority to CA002359986A priority patent/CA2359986A1/en
Priority to DE60005300T priority patent/DE60005300T2/de
Priority to IDW00200101520A priority patent/ID30351A/id
Priority to ARP000100086A priority patent/AR022235A1/es
Priority to HR20010529A priority patent/HRP20010529B1/xx
Priority to HU0105116A priority patent/HUP0105116A3/hu
Priority to ES00900088T priority patent/ES2206176T3/es
Priority to SK10132001A priority patent/SK284241B6/sk
Priority to EP00900088A priority patent/EP1147119B1/en
Priority to PT00900088T priority patent/PT1147119E/pt
Priority to CNB008048525A priority patent/CN1167707C/zh
Priority to MXPA01007187A priority patent/MXPA01007187A/es
Priority to NZ527483A priority patent/NZ527483A/en
Priority to AU18861/00A priority patent/AU768511B2/en
Priority to HK02103017.1A priority patent/HK1041270B/en
Priority to YU50701A priority patent/YU50701A/sh
Priority to NZ512852A priority patent/NZ512852A/xx
Priority to MYPI20000121A priority patent/MY121135A/en
Priority to PA20008489901A priority patent/PA8489901A1/es
Priority to CO00001575A priority patent/CO5180591A1/es
Priority to CR6423A priority patent/CR6423A/xx
Priority to MA26266A priority patent/MA25342A1/fr
Priority to BG105745A priority patent/BG105745A/xx
Priority to US10/611,385 priority patent/US7491677B2/en
Priority to US10/611,093 priority patent/US7005422B2/en
Priority to US10/611,386 priority patent/US7005516B2/en
Priority to US10/611,091 priority patent/US20040018995A1/en
Priority to US10/610,719 priority patent/US7037899B2/en
Publication of IN190975B publication Critical patent/IN190975B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IN86DE1999 1999-01-15 1999-01-15 IN190975B (enExample)

Priority Applications (38)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (enExample) 1999-01-15 1999-01-15
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors
TR2001/02043T TR200102043T2 (tr) 1999-01-15 2000-01-10 Hücre yapışma önleyicileri olarak monosakkaritlerin 2,3-O-izopropiliden türevleri.
AT00900088T ATE250074T1 (de) 1999-01-15 2000-01-10 2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion- inhibitoren
BR0007553-1A BR0007553A (pt) 1999-01-15 2000-01-10 Derivados de 2,3-o-isopropilideno demonossacarìdeos com atividade inibidora deaderência celular
JP2000593621A JP2002534530A (ja) 1999-01-15 2000-01-10 細胞癒着阻害剤としての単糖の２，３−ｏ−イソプロピリデン誘導体
DK00900088T DK1147119T3 (da) 1999-01-15 2000-01-10 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer
CZ20012540A CZ20012540A3 (cs) 1999-01-15 2000-01-10 2,3-O-izopropylidenové deriváty monosacharidů jako inhibitory buněčné adheze a způsob jejich přípravy
IL14427300A IL144273A0 (en) 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
PCT/IB2000/000022 WO2000042054A1 (en) 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
CA002359986A CA2359986A1 (en) 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
DE60005300T DE60005300T2 (de) 1999-01-15 2000-01-10 2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion-inhibitoren
IDW00200101520A ID30351A (id) 1999-01-15 2000-01-10 Derivatip-derivatip 2,3-0-isopropylidene monosakarida sebagai penghambat perekatan sel
ARP000100086A AR022235A1 (es) 1999-01-15 2000-01-10 Derivados de monosacaridos como inhibidores de la adhesion celular
HR20010529A HRP20010529B1 (en) 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
HU0105116A HUP0105116A3 (en) 1999-01-15 2000-01-10 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors, pharmaceutical compositions containing them, process for preparation of the compounds
ES00900088T ES2206176T3 (es) 1999-01-15 2000-01-10 Derivados de 2,3-o-isopropilideno de monosacaridos y su utilizacion como inhibidores de la adhesion celular.
SK10132001A SK284241B6 (en) 1999-01-15 2000-01-10 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
EP00900088A EP1147119B1 (en) 1999-01-15 2000-01-10 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
PT00900088T PT1147119E (pt) 1999-01-15 2000-01-10 Derivados 2,3-o-isopropilideno de monossacaridos como inibidores de adesao celular
CNB008048525A CN1167707C (zh) 1999-01-15 2000-01-10 作为细胞粘连抑制剂的单糖的2,3-o-异亚丙基衍生物
MXPA01007187A MXPA01007187A (es) 1999-01-15 2000-01-10 Derivados de 2, 3-o-isopropilideno de monosacaridos como inhibidores de adhesion celular.
NZ527483A NZ527483A (en) 1999-01-15 2000-01-10 Isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
AU18861/00A AU768511B2 (en) 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
HK02103017.1A HK1041270B (en) 1999-01-15 2000-01-10 2,-3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
YU50701A YU50701A (sh) 1999-01-15 2000-01-10 2,3-o-izopropiliden derivati monosaharida kao inhibitori ćelijske adhezije
NZ512852A NZ512852A (en) 1999-01-15 2000-01-10 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
MYPI20000121A MY121135A (en) 1999-01-15 2000-01-14 Derivatives of monosaccharides as cell adhesion inhibitors.
PA20008489901A PA8489901A1 (es) 1999-01-15 2000-01-14 Derivados de monosacaridos como inhibidores de adhesion celular
CO00001575A CO5180591A1 (es) 1999-01-15 2000-01-14 Derivados de 4 carbamato-6-deoxi-a-l-xilo-2-hexulofuranosa .
CR6423A CR6423A (enExample) 1999-01-15 2001-07-12
MA26266A MA25342A1 (fr) 1999-01-15 2001-07-12 2,3,-o-derives d'isopropylidene de monosaccharides utilises en tant qu'inhibiteurs d'adhesion de cellules.
BG105745A BG105745A (en) 1999-01-15 2001-07-26 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
US10/611,385 US7491677B2 (en) 1999-01-15 2003-07-01 Combinatorial synthesis
US10/611,093 US7005422B2 (en) 1999-01-15 2003-07-01 Derivatives of monosaccharides as cell adhesion inhibitors
US10/611,386 US7005516B2 (en) 1999-01-15 2003-07-01 Derivatives of monosaccharides as cell adhesion inhibitors
US10/611,091 US20040018995A1 (en) 1999-01-15 2003-07-01 Derivatives of monosaccharides as cell adhesion inhibitors
US10/610,719 US7037899B2 (en) 1999-01-15 2003-07-01 Derivatives of monosaccharides as cell adhesion inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (enExample) 1999-01-15 1999-01-15

Publications (1)

Publication Number Publication Date
IN190975B true IN190975B (enExample) 2003-09-06

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
IN86DE1999 IN190975B (enExample) 1999-01-15 1999-01-15

Country Status (30)

Country Link
US (5) US6590085B1 (enExample)
EP (1) EP1147119B1 (enExample)
JP (1) JP2002534530A (enExample)
CN (1) CN1167707C (enExample)
AR (1) AR022235A1 (enExample)
AT (1) ATE250074T1 (enExample)
AU (1) AU768511B2 (enExample)
BG (1) BG105745A (enExample)
BR (1) BR0007553A (enExample)
CA (1) CA2359986A1 (enExample)
CO (1) CO5180591A1 (enExample)
CR (1) CR6423A (enExample)
CZ (1) CZ20012540A3 (enExample)
DE (1) DE60005300T2 (enExample)
DK (1) DK1147119T3 (enExample)
ES (1) ES2206176T3 (enExample)
HR (1) HRP20010529B1 (enExample)
HU (1) HUP0105116A3 (enExample)
ID (1) ID30351A (enExample)
IN (1) IN190975B (enExample)
MA (1) MA25342A1 (enExample)
MX (1) MXPA01007187A (enExample)
MY (1) MY121135A (enExample)
NZ (2) NZ527483A (enExample)
PA (1) PA8489901A1 (enExample)
PT (1) PT1147119E (enExample)
SK (1) SK284241B6 (enExample)
TR (1) TR200102043T2 (enExample)
WO (1) WO2000042054A1 (enExample)
YU (1) YU50701A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
CN1812983A (zh) 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
WO2006024926A1 (en) * 2004-09-02 2006-03-09 Ranbaxy Laboratories Limited Monosaccharide derivatives
WO2007063356A2 (en) * 2004-12-22 2007-06-07 Ranbaxy Laboratories Limited Derivatives of pentose monosaccharides as anti-inflammatory compounds
WO2007010499A2 (en) * 2005-07-22 2007-01-25 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
BRPI0618379A2 (pt) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
US20080114031A1 (en) * 2006-03-29 2008-05-15 Sattigeri Viswajanani J Monosaccharide derivatives
US7790689B2 (en) * 2006-05-30 2010-09-07 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20080300196A1 (en) * 2006-10-03 2008-12-04 Ashwani Kumar Verma Monosaccharide derivatives
US10034995B2 (en) * 2007-09-20 2018-07-31 Resmed Limited Retractable tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) * 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
ATE250074T1 (de) 2003-10-15
MY121135A (en) 2005-12-30
PT1147119E (pt) 2004-02-27
EP1147119A1 (en) 2001-10-24
SK284241B6 (en) 2004-11-03
ID30351A (id) 2001-11-22
CN1167707C (zh) 2004-09-22
PA8489901A1 (es) 2000-09-29
YU50701A (sh) 2005-06-10
AR022235A1 (es) 2002-09-04
US7005422B2 (en) 2006-02-28
DE60005300D1 (de) 2003-10-23
MXPA01007187A (es) 2002-04-24
NZ512852A (en) 2004-02-27
HUP0105116A2 (hu) 2003-04-28
ES2206176T3 (es) 2004-05-16
BG105745A (en) 2002-05-31
US20040029820A1 (en) 2004-02-12
DE60005300T2 (de) 2004-07-15
US7005516B2 (en) 2006-02-28
JP2002534530A (ja) 2002-10-15
HUP0105116A3 (en) 2003-05-28
WO2000042054A1 (en) 2000-07-20
US20040018995A1 (en) 2004-01-29
US7037899B2 (en) 2006-05-02
US20040023900A1 (en) 2004-02-05
US20040019191A1 (en) 2004-01-29
CZ20012540A3 (cs) 2002-02-13
AU1886100A (en) 2000-08-01
TR200102043T2 (tr) 2001-11-21
US6590085B1 (en) 2003-07-08
HK1041270A1 (en) 2002-07-05
DK1147119T3 (da) 2004-01-19
CA2359986A1 (en) 2000-07-20
MA25342A1 (fr) 2001-12-31
NZ527483A (en) 2005-02-25
CR6423A (enExample) 2004-03-09
EP1147119B1 (en) 2003-09-17
BR0007553A (pt) 2001-12-18
CN1343213A (zh) 2002-04-03
HRP20010529A2 (en) 2002-08-31
HRP20010529B1 (en) 2005-02-28
CO5180591A1 (es) 2002-07-30
SK10132001A3 (sk) 2002-01-07
AU768511B2 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
BE2018C020I2 (enExample)
BE2015C057I2 (enExample)
BE2016C007I2 (enExample)
BE2015C018I2 (enExample)
BE2014C017I2 (enExample)
BE2013C051I2 (enExample)
BE2013C020I2 (enExample)
BE2013C015I2 (enExample)
BE2013C001I2 (enExample)
BE2012C036I2 (enExample)
BE1025464I2 (enExample)
BE2008C046I2 (enExample)
JP2002514797A5 (enExample)
BE2010C011I2 (enExample)
JP2002529114A5 (enExample)
BE2008C047I2 (enExample)
JP2002508995A5 (enExample)
BE2011C004I2 (enExample)
BRPI0001672A2 (enExample)
JP2002527459A5 (enExample)
JP2002502779A5 (enExample)
JP2002520668A5 (enExample)
JP2001143032A5 (enExample)
IN190975B (enExample)
JP2002518157A5 (enExample)